Hcw Biologics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.04

+0.05 (+5.05%)

As of Feb 8, 2:33 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +1,792.3% upside

Low Target $12.72

Average Target $19.68

High Target $25.92

Current Price $1.04

Current
$1.04

Target
$19.68

$12.72 $19.68 avg $25.92

Scenario Analysis

Bear Case

$12.72

1,123.1%

Low target

Base Case

$19.68

+1,792.3%

Avg target

Bull Case

$25.92

+2,392.3%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$18.64

-94.4% from high

52-Week Low

$10.63

+-90.2% from low

Target vs 52W High

$19.68

+5.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%